Clinical heterogeneity in Hallervorden-Spatz syndrome: A clinicoradiological study in 13 patients from South India

Brain and Development

Volumn 28, Issue 6, 2006, Pages 343-347

  Bindu, P S ^a   Desai, Sunali ^a   Shehanaz, K E ^a   Nethravathy, M ^a   Pal, Pramod K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Dystonia; Eye of tiger; Globus pallidus; Hallervorden spatz syndrome; MRI

Indexed keywords

ACANTHOCYTOSIS; ADOLESCENT; ADULT; ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; DYSTONIA; FEMALE; GAIT DISORDER; GENETIC HETEROGENEITY; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HUMAN; HUMAN CELL; INCIDENCE; INDIA; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE ATROPHY; PHENOTYPE;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DYSTONIA; FEMALE; GAIT APRAXIA; GLOBUS PALLIDUS; HALLERVORDEN-SPATZ SYNDROME; HUMANS; INDIA; MAGNETIC RESONANCE IMAGING; MALE; PHENOTYPE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646152531     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2005.11.007     Document Type: Article

References (15)

1. Swaiman K.F. Hallervorden-Spatz syndrome. Pediatr Neurol 25 (2001) 102-108
2. Zhou B., Westaway S.K., Levinson B., Johnson M.A., Gistschier J., and Hayflick S.J. A novel Pantothenate kinase gene (PANK 2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28 (2001) 345-349
3. Swaiman K.F. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 48 (1991) 1285-1293
4. Dooling E.C., Schoene W.C., and Richardson Jr. E.P. Hallervorden-Spatz syndrome. Arch Neurol 30 (1974) 70-83
5. Ostergaard J.R., Christensen T., and Hansen K.N. In vivo diagnosis of Hallervorden-Spatz disease. Dev Med Child Neurol 37 (1995) 827-833
6. Pena J., Molino O., and Cardozo J. Hallervorden-Spatz disease: two new early childhood onset cases. J Child Neurol 15 (2000) 30-32
7. Newell F.W., Johnson II R.O., and Huttenlocher P.R. Pigmentary degeneration of the retina in the Hallervorden-Spatz syndrome. Am J Ophthalmol 88 (1979) 467-471
8. Casteels I., Spileers W., Swinnen T., Demaerel P., Silberstein J., Casaer P., et al. Optic atrophy as the presenting sign in Hallervorden-Spatz syndrome. Neuropaediatrics 25 (1994) 265-267
9. Battistella P.A., Midena E., Suppiej A., and Carollo C. Optic atrophy as the first symptom in Hallervorden-Spatz syndrome. Childs Nerv Syst 14 (1998) 135-138
10. Muthane U.B., Shetty R., Panda K., Yasha T.C., Jayakumar P.N., and Taly A.B. Hallervorden-Spatz disease and acanthocytes. Neurology 53 (1999) 32A
11. Hayflick S.J., Westaway S.K., Levinson B., Zhou B., Johnson M.A., Ching K.H., Gitschier J., et al. Genetic, clinical and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 348 (2003) 33-40
12. Sethi K.D., Adams R.J., Loring D.W., and el Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 24 (1988) 692-694
13. Guillerman R.P. The eye-of-the-tiger sign. Radiology 217 (2000) 895-896
14. Bradley W.G. Pathophysiological correlates of signal alterations. In: Brant-Zwadzki M., and Norman D. (Eds). Magnetic resonance imaging of the central nervous system (1987), Raven Press, New York 29
15. Tennison M.B., Bouldin T.W., and Whaley R.A. Mineralisation of the basal ganglia detected by CT in Hallervorden-Spatz syndrome. Neurology 38 (1988) 154-155